Core Scientific, Inc/tx Form 4 insider transactions

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on August 10, 2026.

Mark Adams, a Director of Core Scientific, Inc./tx, received 27,594 shares of common stock on July 30, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on July 27, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on July 20, 2026 for $22.30 per share.

Adam Taylor Sullivan, Chief Executive Officer and a Director of Core Scientific, Inc./tx, reported a transaction in 15,584 shares of common stock on July 16, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, reported a transaction in 4,325 shares of common stock on July 16, 2026.

Todd M Duchene, See remarks of Core Scientific, Inc./tx, sold 10,000 shares of common stock on July 13, 2026.

Core Scientific, Inc. reports that Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of common stock for $22.625 per share as part of a pre-arranged trading plan.

Core Scientific, Inc. CEO Adam Sullivan reported a transaction involving the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Core Scientific, Inc. executive Todd DuChene reported the sale of common stock under a pre-arranged trading plan, with transactions occurring on June 29 and June 30, 2026.

Core Scientific, Inc. officer Todd M. Duchene reported the sale of 10,000 shares of common stock under a pre-arranged trading plan.

Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc., reported the sale of 9,900 shares of common stock for $28.1875 each, executed under a pre-arranged trading plan.

Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of Core Scientific common stock via a 10b5-1 plan.

Core Scientific, Inc. reports that executive Todd DuChene sold a total of 10,000 shares of common stock under a pre-arranged trading plan.

Director Stephen M. Smith was granted 18,961 restricted stock units as part of his compensation package.

Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of Core Scientific common stock via a 10b5-1 plan.

Core Scientific EVP and CFO James P. Nygaard Jr. was granted 120,074 restricted stock units as part of an annual equity award.

Chief Legal and Administrative Officer Todd DuChene was granted 138,547 restricted stock units as part of an annual award.

Core Scientific, Inc. officer Todd Duchene sold shares of common stock valued at approximately $230,000 through a pre-arranged trading plan.

Core Scientific, Inc. reports that executive Todd M. Duchene sold shares of common stock as part of a pre-arranged trading plan.

Todd Duchene, Chief Legal and Administrative Officer of Core Scientific, Inc., reported the sale of 9,900 shares of common stock for $20.8499 per share and 100 shares for $21.53 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Core Scientific, Inc. reports that Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of common stock for $19.7952 per share, executed under a pre-arranged trading plan.

Chief Legal and Administrative Officer Todd M. DuChene disposed of 16,741 shares of Core Scientific, Inc. to cover tax liabilities following the vesting of restricted stock units.

CEO Adam Taylor Sullivan had 87,355 shares withheld to cover tax liabilities upon the vesting of restricted stock units.

Core Scientific, Inc. officer Todd DuChene reported the sale of common stock through a pre-arranged trading plan.

Core Scientific, Inc. officer Todd Duchene sold 10,000 shares of common stock for approximately $1.65 million under a pre-arranged trading plan.

Core Scientific CEO Adam Sullivan reported transactions involving restricted stock units and tax withholdings on March 31, 2026.

Core Scientific's Chief Legal Officer, Todd DuChene, reported transactions involving common stock, including a PSU grant settlement and share sales under a pre-arranged trading plan.

Core Scientific's CFO, James P Nygaard Jr., filed an amended Form 4 to correct the number of shares withheld for tax obligations related to restricted stock unit vesting.

Core Scientific's CFO, James P Nygaard Jr., reported the withholding of shares for tax obligations and the acquisition of additional shares from distributions.